ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 6.1 | 2.0 | 5.8 |
| Other income | 0.1 | 0.2 | 0.1 |
| Total income | 6.2 | 2.2 | 5.9 |
| Profit before exceptional items & tax | 0.2 | -0.4 | 0.2 |
| Profit before tax | 0.2 | -0.4 | 0.2 |
| Net profit | 0.2 | 0.6 | 0.2 |
| Operating margin | 3.2% | -18.2% | 3.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +0.00% |
|---|---|
| Net profit, quarter on quarter | -66.70% |
| Revenue, year on year | +5.20% |
| Operating profit, quarter on quarter | +116.70% |
BSE results filing, NSE: BRAWN. Figures extracted from the filing.
Brawn Biotech Ltd: key numbers
- Share price
- ₹22.00
- Market cap
- ₹6.60 Cr
- Revenue (annual)
- ₹16.98 Cr
- Net profit (annual)
- ₹0.94 Cr
- P/E (TTM)
- 8.1×Sector 43.8×
- Promoter holding
- 52.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Brawn Biotech Ltd
All →Brawn Biotech Other Announcement
Brawn Biotech declared related party transaction filing under Regulation 23(9) non-applicable for FY 2025-26. Its paid-up capital and net worth are below the exemption thresholds.
Brawn Biotech Q2 FY27 Results: Net Profit ₹0 Cr
Brawn Biotech Ltd reported revenue from operations of ₹5.6 Cr (+14.3% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Brawn Biotech Board Meeting Date
Brawn Biotech intimated a board meeting on 05 Nov 2026 to consider un-audited Q2 FY27 results. The trading window stays closed till 16 Nov 2026.
Brawn Biotech Other Announcement
Brawn Biotech Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026. The filing includes details on promoter and public shareholding.
Brawn Biotech Other Announcement
Brawn Biotech Ltd members approved the appointment of M/s. GDSM and Co. as Statutory Auditors. Mr. Brij Raj Gupta was also re-appointed as Director at the Annual General Meeting.
Brawn Biotech Annual General Meeting
Brawn Biotech Ltd held its 41st Annual General Meeting on September 29, 2026. All resolutions were passed by the shareholders with the requisite majority.